SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-003601
Filing Date
2020-03-09
Accepted
2020-03-09 16:22:40
Documents
18
Period of Report
2020-03-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 28485
2 ex99-1.htm EX-99.1 15096
3 ex99-1_001.jpg GRAPHIC 90490
4 ex99-1_002.jpg GRAPHIC 284211
5 ex99-1_003.jpg GRAPHIC 154566
6 ex99-1_004.jpg GRAPHIC 203720
7 ex99-1_005.jpg GRAPHIC 146426
8 ex99-1_006.jpg GRAPHIC 181581
9 ex99-1_007.jpg GRAPHIC 131549
10 ex99-1_008.jpg GRAPHIC 99730
11 ex99-1_009.jpg GRAPHIC 95431
12 ex99-1_010.jpg GRAPHIC 144342
13 ex99-1_011.jpg GRAPHIC 117556
14 ex99-1_012.jpg GRAPHIC 177966
15 ex99-1_013.jpg GRAPHIC 121051
16 ex99-1_014.jpg GRAPHIC 172889
17 ex99-1_015.jpg GRAPHIC 119677
18 ex99-1_016.jpg GRAPHIC 91323
  Complete submission text file 0001493152-20-003601.txt   3258384
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 20698234
SIC: 2834 Pharmaceutical Preparations